Profil News

Our expert

Dr. Lars Bochmann

Director Marketing & Business Development

November 26, 2019

Profil World - The clinical diabetes research newsletter - November 2019

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

November 14, 2019

Lipohypertrophy – New insights into an old issue?

Lipohypertrophy (LH) is a common side effect of insulin therapy in patients with diabetes mellitus. The prevalence of lipohypertrophy is high with cross-sectional studies reporting up to 64% of

October 17, 2019

What news in the treatment of Type 2 diabetes was presented at EASD 2019?

The annual meeting of the European Association for the Study of Diabetes (EASD) took place this year in Barcelona, Spain. The present text offers a selection of topics relevant for the field of type

October 1, 2019

Finally breakthrough in the immunological approach to type 1 diabetes

Type 1 diabetes is a T-cell mediated autoimmune disease. For more than 40 years, researchers have tried to intervene in the autoimmune process to halt or perhaps even reverse the slow destruction of

September 17, 2019

Current developments in approaches to bridging studies

Waiving Bridging studies under certain circumstances for biosimilar applications? A bridging study is a study performed in a new region to provide pharmacodynamic or clinical data on efficacy,

September 3, 2019

iPDM Goes Europe: tangible impact on diabetes patients and care

Treatment inertia calls for an integrated personalized diabetes management: iPDM Diabetes represents a huge and multidimensional challenge for European societes. It not only leads to premature ageing

August 21, 2019

New PID-algorithm for automated glucose clamps

Introduction The euglycemic, hyperinsulinemic glucose clamp is the gold standard for the determination of pharmacokinetic and pharmacodynamic (PK/PD) effects of new anti-diabetic drugs, in particular

July 23, 2019

"Profil World" - The clinical diabetes research newsletter - July 2019

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

July 16, 2019

Dual-hormone artificial pancreas systems

Dual-hormone artificial pancreas systems use insulin and glucagon to control glucose in patients with diabetes - a dream is about to come true Insulin-only closed-loop AP systems hold promise for

Profil Germany News

See what’s new at Profil